SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001104659-20-095626
Filing Date
2020-08-14
Accepted
2020-08-14 17:01:49
Documents
1
Period of Report
2020-08-11

Document Format Files

Seq Description Document Type Size
1 FORM 4/A tm2027654-2_4a.html 4/A  
1 FORM 4/A tm2027654-2_4a.xml 4/A 4510
  Complete submission text file 0001104659-20-095626.txt   6158
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 2161401
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 2161401 972-4-988-9488
Protalix BioTherapeutics, Inc. (Issuer) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O BRAINSTORM CELL THERAPEUTICS INC., 3 UNIVERSITY PLAZA DRIVE, STE 320 HACKENSACK NJ 07601
Business Address
Rubin Eyal (Reporting) CIK: 0001721411 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-33357 | Film No.: 201106372